Laparoscopic Mini-gastric Bypass for Type 2 Diabetes: The Preliminary Report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Zisun | - |
dc.contributor.author | Hur, Kyung Yul | - |
dc.date.accessioned | 2021-08-12T05:46:32Z | - |
dc.date.available | 2021-08-12T05:46:32Z | - |
dc.date.issued | 2011-03 | - |
dc.identifier.issn | 0364-2313 | - |
dc.identifier.issn | 1432-2323 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/16686 | - |
dc.description.abstract | Type 2 diabetes mellitus (T2DM) has become an epidemic health problem worldwide. Compared to Western countries, in Asia, T2DM occurs in patients with a lower body mass index (BMI) due to central obesity and decreased pancreatic beta-cell function. The efficacy of laparoscopic mini-gastric bypass (LMGB) in obese patients with T2DM has been proven by numerous studies. Treatment outcomes of LMGB for non-obese T2DM patients are also estimated to be excellent. The aim of the present pilot study was to evaluate the efficacy and safety of LMBG in non-obese T2DM patients (BMI 25-30 kg/m(2)). Ten consecutive patients underwent LMGB at our hospital from August 2009 to October 2009. Preoperative data including glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG), and 2 h postprandial glucose (2-h PPG) were compared with data collected at 1, 3, and 6 postoperative months. All procedures were completed laparoscopically. Mean age of the patients was 46.9 years, mean BMI was 27.2 kg/m(2), mean operative time was 150.5 min, and mean postoperative hospital stay was 5.3 days. Neither mortality nor major complications occurred. Mean preoperative glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG), 2-h PPG, and C-peptide level were 9.7%, 222 mg/dl, 343 mg/dl, and 2.78 ng/ml, respectively. At the sixth postoperative month, HbA1c, FPG, 2-h PPG, and C-peptide level measured 6.7%, 144 mg/dl, 203 mg/dl, and 2.18 ng/ml. This preliminary study demonstrated the resolution of hyperglycemia in 70% of non-obese T2DM patients (BMI 25-30 kg/m(2)). Although long-term follow-up data are required, early operative outcomes were satisfactory in terms of glycemic control and safety of the procedure. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Verlag | - |
dc.title | Laparoscopic Mini-gastric Bypass for Type 2 Diabetes: The Preliminary Report | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1007/s00268-010-0909-2 | - |
dc.identifier.scopusid | 2-s2.0-79952192911 | - |
dc.identifier.wosid | 000286934700026 | - |
dc.identifier.bibliographicCitation | World Journal of Surgery, v.35, no.3, pp 631 - 636 | - |
dc.citation.title | World Journal of Surgery | - |
dc.citation.volume | 35 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 631 | - |
dc.citation.endPage | 636 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | BARIATRIC SURGERY | - |
dc.subject.keywordPlus | OBESITY-SURGERY | - |
dc.subject.keywordPlus | MORBID-OBESITY | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | MELLITUS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | ULCER | - |
dc.subject.keywordAuthor | Mini-gastric Bypas | - |
dc.subject.keywordAuthor | T2DM patients | - |
dc.subject.keywordAuthor | Glycemic control | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.